Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017

Abstract Background Trends in antimicrobial resistance help inform infection control efforts. We examined trends in resistance for Enterobacteriaceae and Acinetobacter spp. from 2013 to 2017 in hospitalized US patients. Methods We analyzed antimicrobial susceptibility of non-duplicate isolates in ho...

Full description

Bibliographic Details
Main Authors: Vikas Gupta, Gang Ye, Melanie Olesky, Kenneth Lawrence, John Murray, Kalvin Yu
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-019-4387-3
id doaj-5bfe489f0f124fc7a4b5260368cae126
record_format Article
spelling doaj-5bfe489f0f124fc7a4b5260368cae1262020-11-25T03:55:48ZengBMCBMC Infectious Diseases1471-23342019-08-011911910.1186/s12879-019-4387-3Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017Vikas Gupta0Gang Ye1Melanie Olesky2Kenneth Lawrence3John Murray4Kalvin Yu5Becton, Dickinson and CompanyBecton, Dickinson and CompanyTetraphase PharmaceuticalsTetraphase PharmaceuticalsBecton, Dickinson and CompanyBecton, Dickinson and CompanyAbstract Background Trends in antimicrobial resistance help inform infection control efforts. We examined trends in resistance for Enterobacteriaceae and Acinetobacter spp. from 2013 to 2017 in hospitalized US patients. Methods We analyzed antimicrobial susceptibility of non-duplicate isolates in hospitalized patients (not limited to hospital-acquired infections) in the US BD Insights Research Database. Resistance profiles of interest were extended-spectrum beta-lactamase (ESBL)-producing, multidrug resistant (MDR), and carbapenem-nonsusceptible (Carb-NS) phenotypes of Enterobacteriaceae, and MDR and Carb-NS Acinetobacter spp. Time series models were used to evaluate the patterns of resistance trends in rate per 100 hospital admissions and proportion per isolates tested. Results More than 1 million Enterobacteriaceae isolates were obtained from 411 hospitals; 12.05% were ESBL, 1.21% Carb-NS, and 7.08% MDR. Urine was the most common source. For Acinetobacter spp. (n = 19,325), 37.48% were Carb-NS, 47.66% were MDR, and the most common source was skin/wound cultures. Trend analyses showed that the rates of ESBL and Carb-NS Enterobacteriaceae per 100 hospital admissions increased significantly between 2013 and 2017. Rates of MDR Enterobacteriaceae and Carb-NS and MDR Acinetobacter spp. decreased during this time period. Trends in proportions of resistant isolates generally mirrored trends in rates per 100 hospital admissions. MDR Enterobacteriaceae and Carb-NS and MDR Acinetobacter spp. were more common in winter than summer. Conclusions In this large-scale study of patients in US hospitals, rates of ESBL and Carb-NS Enterobacteriaceae per 100 hospital admissions increased between 2013 and 2017. MDR Enterobacteriaceae and MDR and Carb-NS Acinetobacter spp. isolates decreased over this period. These data support continuing infection control and stewardship efforts and the development of new therapeutic options.http://link.springer.com/article/10.1186/s12879-019-4387-3Antimicrobial resistanceAcinetobacterEnterobacteriaceaeUnited StatesCarbapenemsExtended-spectrum beta-lactamases
collection DOAJ
language English
format Article
sources DOAJ
author Vikas Gupta
Gang Ye
Melanie Olesky
Kenneth Lawrence
John Murray
Kalvin Yu
spellingShingle Vikas Gupta
Gang Ye
Melanie Olesky
Kenneth Lawrence
John Murray
Kalvin Yu
Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
BMC Infectious Diseases
Antimicrobial resistance
Acinetobacter
Enterobacteriaceae
United States
Carbapenems
Extended-spectrum beta-lactamases
author_facet Vikas Gupta
Gang Ye
Melanie Olesky
Kenneth Lawrence
John Murray
Kalvin Yu
author_sort Vikas Gupta
title Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
title_short Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
title_full Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
title_fullStr Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
title_full_unstemmed Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
title_sort trends in resistant enterobacteriaceae and acinetobacter species in hospitalized patients in the united states: 2013–2017
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2019-08-01
description Abstract Background Trends in antimicrobial resistance help inform infection control efforts. We examined trends in resistance for Enterobacteriaceae and Acinetobacter spp. from 2013 to 2017 in hospitalized US patients. Methods We analyzed antimicrobial susceptibility of non-duplicate isolates in hospitalized patients (not limited to hospital-acquired infections) in the US BD Insights Research Database. Resistance profiles of interest were extended-spectrum beta-lactamase (ESBL)-producing, multidrug resistant (MDR), and carbapenem-nonsusceptible (Carb-NS) phenotypes of Enterobacteriaceae, and MDR and Carb-NS Acinetobacter spp. Time series models were used to evaluate the patterns of resistance trends in rate per 100 hospital admissions and proportion per isolates tested. Results More than 1 million Enterobacteriaceae isolates were obtained from 411 hospitals; 12.05% were ESBL, 1.21% Carb-NS, and 7.08% MDR. Urine was the most common source. For Acinetobacter spp. (n = 19,325), 37.48% were Carb-NS, 47.66% were MDR, and the most common source was skin/wound cultures. Trend analyses showed that the rates of ESBL and Carb-NS Enterobacteriaceae per 100 hospital admissions increased significantly between 2013 and 2017. Rates of MDR Enterobacteriaceae and Carb-NS and MDR Acinetobacter spp. decreased during this time period. Trends in proportions of resistant isolates generally mirrored trends in rates per 100 hospital admissions. MDR Enterobacteriaceae and Carb-NS and MDR Acinetobacter spp. were more common in winter than summer. Conclusions In this large-scale study of patients in US hospitals, rates of ESBL and Carb-NS Enterobacteriaceae per 100 hospital admissions increased between 2013 and 2017. MDR Enterobacteriaceae and MDR and Carb-NS Acinetobacter spp. isolates decreased over this period. These data support continuing infection control and stewardship efforts and the development of new therapeutic options.
topic Antimicrobial resistance
Acinetobacter
Enterobacteriaceae
United States
Carbapenems
Extended-spectrum beta-lactamases
url http://link.springer.com/article/10.1186/s12879-019-4387-3
work_keys_str_mv AT vikasgupta trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017
AT gangye trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017
AT melanieolesky trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017
AT kennethlawrence trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017
AT johnmurray trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017
AT kalvinyu trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017
_version_ 1724467953821286400